Fukushima M - Search Results

1

Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil.

Mizutani Y, Nakanishi H, Yoshida O, Fukushima M, Bonavida B, Miki T. Mizutani Y, et al. Among authors: fukushima m. Eur J Cancer. 2002 Jan;38(1):167-76. doi: 10.1016/s0959-8049(01)00339-2. Eur J Cancer. 2002. PMID: 11750847

2

The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer.

Mizutani Y, Wada H, Fukushima M, Yoshida O, Ukimura O, Kawauchi A, Miki T. Mizutani Y, et al. Among authors: fukushima m. Eur J Cancer. 2001 Mar;37(5):569-75. doi: 10.1016/s0959-8049(00)00440-8. Eur J Cancer. 2001. PMID: 11290431

3

Prognostic significance of thymidylate synthase activity in bladder carcinoma.

Mizutani Y, Wada H, Ogawa O, Yoshida O, Fukushima M, Nonomura N, Miki T. Mizutani Y, et al. Among authors: fukushima m. Cancer. 2001 Aug 1;92(3):510-8. doi: 10.1002/1097-0142(20010801)92:3<510::aid-cncr1349>3.0.co;2-0. Cancer. 2001. PMID: 11505394

4

Significance of dihydropyrimidine dehydrogenase activity in renal cell carcinoma.

Mizutani Y, Wada H, Yoshida O, Fukushima M, Nakanishi H, Nakao M, Miki T. Mizutani Y, et al. Among authors: fukushima m. Eur J Cancer. 2003 Mar;39(4):541-7. doi: 10.1016/s0959-8049(02)00730-x. Eur J Cancer. 2003. PMID: 12751387

5

Cisplatin-induced in vivo differentiation of human embryonal carcinoma.

Mizutani Y, Sato N, Kawauchi A, Nonomura N, Fukushima M, Miki T. Mizutani Y, et al. Among authors: fukushima m. BJU Int. 2002 Mar;89(4):454-8. doi: 10.1046/j.1464-4096.2001.01794.x. BJU Int. 2002. PMID: 11872042

6

A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance.

Yamachika T, Nakanishi H, Inada K, Tsukamoto T, Kato T, Fukushima M, Inoue M, Tatematsu M. Yamachika T, et al. Among authors: fukushima m. Cancer. 1998 Jan 1;82(1):70-7. Cancer. 1998. PMID: 9428481

7

Differential growth inhibition by 5-fluorouracil in human colorectal carcinoma cell lines.

Tokunaga E, Oda S, Fukushima M, Maehara Y, Sugimachi K. Tokunaga E, et al. Among authors: fukushima m. Eur J Cancer. 2000 Oct;36(15):1998-2006. doi: 10.1016/s0959-8049(00)00200-8. Eur J Cancer. 2000. PMID: 11000583

8

Chromosomal imbalances associated with acquired resistance to fluoropyrimidines in human colorectal cancer cells.

Hidaka S, Yasutake T, Fukushima M, Yano H, Haseba M, Tsuji T, Sawai T, Yamaguchi H, Nakagoe T, Ayabe H, Tagawa Y. Hidaka S, et al. Among authors: fukushima m. Eur J Cancer. 2003 May;39(7):975-80. doi: 10.1016/s0959-8049(03)00028-5. Eur J Cancer. 2003. PMID: 12706367

9

Superior antitumour activity of S-1 in tumours with a high dihydropyrimidine dehydrogenase activity.

Fujiwara H, Terashima M, Irinoda T, Takagane A, Abe K, Nakaya T, Yonezawa H, Oyama K, Takahashi M, Saito K, Takechi T, Fukushima M, Shirasaka T. Fujiwara H, et al. Among authors: fukushima m. Eur J Cancer. 2003 Nov;39(16):2387-94. doi: 10.1016/s0959-8049(03)00513-6. Eur J Cancer. 2003. PMID: 14556932

10

Enhancement of the antitumour activity of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase activity (DPD) using 5-chloro-2,4-dihydroxypyridine (CDHP) in human tumour cells.

Takechi T, Fujioka A, Matsushima E, Fukushima M. Takechi T, et al. Among authors: fukushima m. Eur J Cancer. 2002 Jun;38(9):1271-7. doi: 10.1016/s0959-8049(02)00048-5. Eur J Cancer. 2002. PMID: 12044515

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,011 results

Search Page

Filters